Top Performing Drug of 2021 – Darzalex (March Edition)

Shots:The ongoing series of the top-performing drugs of 2021 based on revenue is continued by Darzalex as the top-performing drug for March monthDarzalex is a CD38-directed cytolytic antibody indicated for the treatment of adult patients with multiple myeloma in combination with different drugsThe report summarizes the key features of Darzalex including revenue…

BySenior EditorMarch 21, 2023

INSIGHTS+

Top Performing Drug of 2021 – Imbruvica (January Edition)

Active Ingredient: Ibrutinib Dosage Forms & Strengths: Capsules: 70 mg and 140 mg Tablets: 140 mg, 280 mg, 420 mg, and 560 mg Mechanism of Action: Bruton's tyrosine kinase Inhibitor (BTKi) First Approval: US (13 Nov 2013), EU (Oct 2014)  Revenue AnalysisImbruvica is an oral therapy that inhibits a protein called Bruton's tyrosine kinase. Imbruvica was one…

BySenior EditorJanuary 25, 2023

INSIGHTS+

Top Performing Drug of 2021 – Xarelto (November Edition)

Active Ingredient: rivaroxaban Strength: 2.5 mg, 10 mg, 15 mg, and 20 mg Dosage Form: Tablets Mechanism of Action: Factor Xa inhibitors First Approval: US (1 Jul 2011), EU (30 Sep 2008) Revenue Analysis of Xarelto1 Xarelto has been an important driver of the revenue generated from the cardiovascular portfolio of Janssen. The blood thinner showed an increase of 4%…

BySenior EditorNovember 24, 2022

Top Performing Drug of 2021 – Darzalex (March Edition)

Top Performing Drug of 2021 – Imbruvica (January Edition)

Top Performing Drug of 2021 – Xarelto (November Edition)

Contact US

OUR INFORMATION

FOLLOW US